ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

New Approaches To Improve Diagnoses In Urogenital Cancers Presented At AUA

September 24, 2004

In Brief: Six Major NIH Positions Now Open; M.D. Anderson Plans More Than $25 Million In Construction

August 21, 1981

NCI Statisticians Disputes Bross Claim

April 27, 1979

NCI-Approved Clinical Trials

July 25, 2003

Patient’s Husband To Fund Fellowship At Dana-Farber

September 8, 1995